EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Randomized Controlled Pilot Trial Evaluating the Efficacy of Intravaginal and Extravaginal K-Laser Therapy as a Personalized Non-Hormonal Treatment for Genitourinary Syndrome of Menopause

Rocío Martín-Valero iD, Antonia M Ruiz-Moreno iD, Pablo J Gallardo-García, María Dolores Martínez Colmena, Catalina Muñoz Pagan, Pedro González-Rojas iD, Paloma Ortega Quiñonero

Journal of Personalized Medicine · 15.07.2026 · 16 (7) · 378

DOI: 10.3390/jpm16070378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 15.07.2026. Verfasst von Rocío Martín-Valero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy, Faculty of Health Sciences, CTS-1071 Research Group, University of Malaga, Arquitecto Francisco Peñalosa 3, Ampliación C…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Genitourinary Syndrome of Menopause (GSM) negatively affects quality of life in postmenopausal women, causing sexual dysfunction, vaginal atrophy, and pelvic discomfort. Personalized medicine highlights the need for individualized, non-hormonal therapeutic options for women with contraindications to or preferences against hormonal treatment. Non-hormonal therapies, such as laser treatments, have emerged as potential alternatives, but evidence comparing intravaginal and extravaginal K-Laser therapy remains limited. This study aimed to evaluate the efficacy of intravaginal and extravaginal K-Laser therapy on the symptoms of Genitourinary Syndrome of Menopause (GSM) in postmenopausal women.

Methods

In this single-center, randomized, single-blind, placebo-controlled trial, 57 postmenopausal women were randomly assigned to receive either intravaginal and extravaginal K-Laser Cube Plus 30 therapy (n = 36) or a simulated control treatment (n = 21). The primary outcome was sexual function, measured by the Female Sexual Function Index (FSFI). Secondary outcomes included vaginal pH and pelvic floor muscle function assessed via the PERFECT protocol. Outcomes were assessed at baseline and after 6 weeks.

Results

Sixty-seven women were enrolled, and ten were lost to follow-up. The treatment group showed significant improvements over the control group in FSFI (mean difference = 6.38; p < 0.001), PERFECT protocol scores (mean difference = 0.78; p = 0.004), CPPQ-Mohedo (mean difference = 5.44; p < 0.001), and Menopause Rating Scale (mean difference = 6.50; p = 0.017). Significant reductions were also observed in vaginal dryness, vulvar dystrophy, and atrophy (p < 0.001).

Conclusions

Intravaginal and extravaginal K-Laser therapy appears to be a safe and effective non-hormonal treatment for GSM and may support personalized management strategies. However, further well-designed randomized clinical trials with larger samples, longer follow-up of both laser-treated and control groups, and objective outcome measures are needed to provide higher-quality evidence regarding efficacy and identify the patients most likely to benefit.

Schlagwörter

Stichwörter der Autor:innen

Female Sexual Function IndexK-Lasergenitourinary syndrome of menopauseintravaginal lasernon-hormonal therapypelvic floor dysfunction

Autor:innen und Institutionen

  • Department of Physiotherapy, Faculty of Health Sciences, CTS-1071 Research Group, University of Malaga, Arquitecto Francisco Peñalosa 3, Ampliación Campus de Teatinos, 29071 Malaga, Spain.
  • Fundación Juan Cruzado, Calle Paganini, 7, Bailén-Miraflores, 29010 Malaga, Spain.
  • Department of Psychology, University of Malaga, 29071 Malaga, Spain.
  • Department of Obstetrics and Gynecology, Santa Lucía General University Hospital, Minarete Street, 30202 Cartagena, Spain.

ORCID-Profile: Rocío Martín-Valero, Antonia M Ruiz-Moreno, Pedro González-Rojas

Zitieren

APA

Martín-Valero, R., Ruiz-Moreno, A. M., Gallardo-García, P. J., Martínez Colmena, M. D., Muñoz Pagan, C., González-Rojas, P., & Ortega Quiñonero, P. (2026). A Randomized Controlled Pilot Trial Evaluating the Efficacy of Intravaginal and Extravaginal K-Laser Therapy as a Personalized Non-Hormonal Treatment for Genitourinary Syndrome of Menopause. Journal of Personalized Medicine, 16(7), 378. https://doi.org/10.3390/jpm16070378

Vancouver

Martín-Valero R, Ruiz-Moreno AM, Gallardo-García PJ, Martínez Colmena MD, Muñoz Pagan C, González-Rojas P, et al. A Randomized Controlled Pilot Trial Evaluating the Efficacy of Intravaginal and Extravaginal K-Laser Therapy as a Personalized Non-Hormonal Treatment for Genitourinary Syndrome of Menopause. Journal of Personalized Medicine. 2026;16(7):378. doi:10.3390/jpm16070378

BibTeX
@article{MartnValero2026,
  author = {Martín-Valero, Rocío and Ruiz-Moreno, Antonia M and Gallardo-García, Pablo J and Martínez Colmena, María Dolores and Muñoz Pagan, Catalina and González-Rojas, Pedro and Ortega Quiñonero, Paloma},
  title = {A Randomized Controlled Pilot Trial Evaluating the Efficacy of Intravaginal and Extravaginal K-Laser Therapy as a Personalized Non-Hormonal Treatment for Genitourinary Syndrome of Menopause},
  journal = {Journal of Personalized Medicine},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {378},
  doi = {10.3390/jpm16070378}
}
Kostenlos starten →